BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jankowska EA, Malyszko J, Ardehali H, Koc-Zorawska E, Banasiak W, von Haehling S, Macdougall IC, Weiss G, McMurray JJ, Anker SD. Iron status in patients with chronic heart failure. Eur Heart J. 2013;34:827-834. [PMID: 23178646 DOI: 10.1093/eurheartj/ehs377] [Cited by in Crossref: 146] [Cited by in F6Publishing: 114] [Article Influence: 14.6] [Reference Citation Analysis]
Number Citing Articles
1 Kumar V, Santhosh Kumar TR, Kartha CC. Mitochondrial membrane transporters and metabolic switch in heart failure. Heart Fail Rev 2019;24:255-67. [PMID: 30535838 DOI: 10.1007/s10741-018-9756-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
2 Przybyłowski P, Wasilewski G, Bachorzewska-gajewska H, Golabek K, Dobrzycki S, Małyszko J. Growth Differentiation Factor 15 Is Related to Anemia and Iron Metabolism in Heart Allograft Recipients and Patients With Chronic Heart Failure. Transplantation Proceedings 2014;46:2852-5. [DOI: 10.1016/j.transproceed.2014.09.040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
3 Ponikowski P, Kirwan BA, Anker SD, Dorobantu M, Drozdz J, Fabien V, Filippatos G, Haboubi T, Keren A, Khintibidze I, Kragten H, Martinez FA, McDonagh T, Metra M, Milicic D, Nicolau JC, Ohlsson M, Parhomenko A, Pascual-Figal DA, Ruschitzka F, Sim D, Skouri H, van der Meer P, Jankowska EA. Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure. Eur J Heart Fail. 2019;21:1651-1658. [PMID: 31883356 DOI: 10.1002/ejhf.1710] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
4 Brunner-La Rocca HP, Crijns HJ. Iron i.v. in heart failure: ready for implementation? Eur Heart J 2015;36:645-7. [PMID: 25336211 DOI: 10.1093/eurheartj/ehu392] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
5 De Franceschi L, Iolascon A, Taher A, Cappellini MD. Clinical management of iron deficiency anemia in adults: Systemic review on advances in diagnosis and treatment. Eur J Intern Med 2017;42:16-23. [PMID: 28528999 DOI: 10.1016/j.ejim.2017.04.018] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 8.2] [Reference Citation Analysis]
6 Beladan CC, Botezatu SB. Anemia and Management of Heart Failure Patients. Heart Fail Clin 2021;17:195-206. [PMID: 33673945 DOI: 10.1016/j.hfc.2020.12.002] [Reference Citation Analysis]
7 Steinbeck L, Ebner N, Valentova M, Bekfani T, Elsner S, Dahinden P, Hettwer S, Scherbakov N, Schefold JC, Sandek A, Springer J, Doehner W, Anker SD, von Haehling S. Detection of muscle wasting in patients with chronic heart failure using C-terminal agrin fragment: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). Eur J Heart Fail 2015;17:1283-93. [PMID: 26449626 DOI: 10.1002/ejhf.400] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
8 Zhang H, Zhabyeyev P, Wang S, Oudit GY. Role of iron metabolism in heart failure: From iron deficiency to iron overload. Biochim Biophys Acta Mol Basis Dis 2019;1865:1925-37. [PMID: 31109456 DOI: 10.1016/j.bbadis.2018.08.030] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
9 Mcdonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JG, Coats AJ, Crespo-leiro MG, Farmakis D, Gilard M, Heyman S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CS, Lyon AR, Mcmurray JJ, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GM, Ruschitzka F, Skibelund AK. Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica. Revista Española de Cardiología 2022. [DOI: 10.1016/j.recesp.2021.11.027] [Reference Citation Analysis]
10 Hirsch VG, Tongers J, Bode J, Berliner D, Widder JD, Escher F, Mutsenko V, Chung B, Rostami F, Guba‐quint A, Giannitsis E, Schultheiss H, Vogt C, Bauersachs J, Wollert KC, Kempf T. Cardiac iron concentration in relation to systemic iron status and disease severity in non‐ischaemic heart failure with reduced ejection fraction. Eur J Heart Fail 2020;22:2038-46. [DOI: 10.1002/ejhf.1781] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
11 González-Costello J, Comín-Colet J, Lupón J, Enjuanes C, de Antonio M, Fuentes L, Moliner-Borja P, Farré N, Zamora E, Manito N, Pujol R, Bayés-Genis A. Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort study. BMC Cardiovasc Disord 2018;18:206. [PMID: 30382817 DOI: 10.1186/s12872-018-0942-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
12 Fitzsimons S, Poppe KK, Choi Y, Devlin G, Lund M, Lam CS, Troughton R, Richards AM, Doughty RN. Relationship between soluble transferrin receptor and clinical outcomes in patients with Heart Failure According to Ejection Fraction Phenotype: The New Zealand PEOPLE Study. Journal of Cardiac Failure 2022. [DOI: 10.1016/j.cardfail.2021.12.018] [Reference Citation Analysis]
13 Tolppanen H, Mebazaa A. Iron Supplementation in Heart Failure. Curr Emerg Hosp Med Rep 2016;4:206-12. [DOI: 10.1007/s40138-016-0117-y] [Reference Citation Analysis]
14 Nielsen OH, Coskun M, Weiss G. Iron replacement therapy: do we need new guidelines? Curr Opin Gastroenterol 2016;32:128-35. [PMID: 26771951 DOI: 10.1097/MOG.0000000000000247] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
15 Cozon GJ. [Iron deficiency and digestive disorders]. Transfus Clin Biol 2014;21:189-92. [PMID: 25282486 DOI: 10.1016/j.tracli.2014.08.135] [Reference Citation Analysis]
16 Hsieh YP, Huang CH, Lee CY, Chen HL, Lin CY, Chang CC. Hepcidin-25 negatively predicts left ventricular mass index in chronic kidney disease patients. World J Nephrol 2013; 2(2): 38-43 [PMID: 24175264 DOI: 10.5527/wjn.v2.i2.38] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
17 Tkaczyszyn M, Comín-Colet J, Voors AA, van Veldhuisen DJ, Enjuanes C, Moliner-Borja P, Rozentryt P, Poloński L, Banasiak W, Ponikowski P, van der Meer P, Jankowska EA. Iron deficiency and red cell indices in patients with heart failure. Eur J Heart Fail 2018;20:114-22. [PMID: 28386910 DOI: 10.1002/ejhf.820] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
18 Shah Y, Patel D, Khan N. Iron deficiency anemia in IBD: an overlooked comorbidity. Expert Rev Gastroenterol Hepatol 2021;15:771-81. [PMID: 33691543 DOI: 10.1080/17474124.2021.1900730] [Reference Citation Analysis]
19 Ambrosy AP, Gurwitz JH, Tabada GH, Artz A, Schrier S, Rao SV, Barnhart HX, Reynolds K, Smith DH, Peterson PN, Sung SH, Cohen HJ, Go AS; RBC HEART Investigators. Incident anaemia in older adults with heart failure: rate, aetiology, and association with outcomes. Eur Heart J Qual Care Clin Outcomes 2019;5:361-9. [PMID: 30847487 DOI: 10.1093/ehjqcco/qcz010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
20 Zhang S, Zhang F, Du M, Huang K, Wang C. Efficacy and safety of iron supplementation in patients with heart failure and iron deficiency: a meta-analysis. Br J Nutr 2019;121:841-8. [PMID: 30782220 DOI: 10.1017/S000711451900014X] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
21 Mirza FG, Abdul-Kadir R, Breymann C, Fraser IS, Taher A. Impact and management of iron deficiency and iron deficiency anemia in women's health. Expert Rev Hematol 2018;11:727-36. [PMID: 30019973 DOI: 10.1080/17474086.2018.1502081] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
22 Reda S, Motloch LJ, Hoppe UC. [Heart failure and anemia]. Herz 2013;38:597-603. [PMID: 23900390 DOI: 10.1007/s00059-013-3901-4] [Reference Citation Analysis]
23 Fitzsimons S, Yeo TJ, Ling LH, Sim D, Leong KTG, Yeo PSD, Ong HY, Jaufeerally F, Ng TP, Poppe K, Lund M, Devlin G, Troughton R, Lam CSP, Richards AM, Doughty RN. Impact of change in iron status over time on clinical outcomes in heart failure according to ejection fraction phenotype. ESC Heart Fail 2021. [PMID: 34592056 DOI: 10.1002/ehf2.13617] [Reference Citation Analysis]
24 Van Gelder IC, Van Veldhuisen DJ, Lip GY. New oral anticoagulants in heart failure. European Journal of Heart Failure 2013;15:966-73. [DOI: 10.1093/eurjhf/hft135] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
25 Shi K, Tao H, Wu J. Iron deficiency as a good potential prediction of chronic heart failure. American Heart Journal 2013;166:e31. [DOI: 10.1016/j.ahj.2013.08.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
26 Fitzsimons S, Doughty RN. Iron deficiency in patients with heart failure. Eur Heart J Cardiovasc Pharmacother 2015;1:58-64. [DOI: 10.1093/ehjcvp/pvu016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
27 McCullough PA, Uhlig K, Neylan JF, Pergola PE, Fishbane S. Usefulness of Oral Ferric Citrate in Patients With Iron-Deficiency Anemia and Chronic Kidney Disease With or Without Heart Failure. Am J Cardiol 2018;122:683-8. [PMID: 29961562 DOI: 10.1016/j.amjcard.2018.04.062] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
28 Lanser L, Fuchs D, Scharnagl H, Grammer T, Kleber ME, März W, Weiss G, Kurz K. Anemia of Chronic Disease in Patients With Cardiovascular Disease. Front Cardiovasc Med 2021;8:666638. [PMID: 34458328 DOI: 10.3389/fcvm.2021.666638] [Reference Citation Analysis]
29 Langhammer R, Wachter R. [New treatment options of heart failure with reduced ejection fraction]. MMW Fortschr Med 2021;163:28-37. [PMID: 33950447 DOI: 10.1007/s15006-021-9806-x] [Reference Citation Analysis]
30 Dziegala M, Josiak K, Kasztura M, Kobak K, von Haehling S, Banasiak W, Anker SD, Ponikowski P, Jankowska E. Iron deficiency as energetic insult to skeletal muscle in chronic diseases. J Cachexia Sarcopenia Muscle 2018;9:802-15. [PMID: 30178922 DOI: 10.1002/jcsm.12314] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
31 Arora NP, Ghali JK. Anemia and Iron Deficiency in Heart Failure. Heart Failure Clinics 2014;10:281-94. [DOI: 10.1016/j.hfc.2013.11.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
32 Zhabyeyev P, Oudit GY. Unravelling the molecular basis for cardiac iron metabolism and deficiency in heart failure. Eur Heart J 2017;38:373-5. [PMID: 27651442 DOI: 10.1093/eurheartj/ehw386] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
33 Paterek A, Kępska M, Sochanowicz B, Chajduk E, Kołodziejczyk J, Polkowska-Motrenko H, Kruszewski M, Leszek P, Mackiewicz U, Mączewski M. Beneficial effects of intravenous iron therapy in a rat model of heart failure with preserved systemic iron status but depleted intracellular cardiac stores. Sci Rep 2018;8:15758. [PMID: 30361476 DOI: 10.1038/s41598-018-33277-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
34 Dignass A, Farrag K, Stein J. Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions. Int J Chronic Dis 2018;2018:9394060. [PMID: 29744352 DOI: 10.1155/2018/9394060] [Cited by in Crossref: 35] [Cited by in F6Publishing: 45] [Article Influence: 8.8] [Reference Citation Analysis]
35 Sciatti E, Dallapellegrina L, Metra M, Lombardi CM. New drugs for the treatment of chronic heart failure with a reduced ejection fraction: What the future may hold. Journal of Cardiovascular Medicine 2019;20:650-9. [DOI: 10.2459/jcm.0000000000000850] [Cited by in Crossref: 7] [Article Influence: 2.3] [Reference Citation Analysis]
36 Kurz K, Lanser L, Seifert M, Kocher F, Pölzl G, Weiss G. Anaemia, iron status, and gender predict the outcome in patients with chronic heart failure. ESC Heart Fail 2020;7:1880-90. [PMID: 32458571 DOI: 10.1002/ehf2.12755] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
37 Jankowska EA, Wojtas K, Kasztura M, Mazur G, Butrym A, Kalicinska E, Rybinska I, Skiba J, von Haehling S, Doehner W, Anker SD, Banasiak W, Cleland JG, Ponikowski P. Bone marrow iron depletion is common in patients with coronary artery disease. International Journal of Cardiology 2015;182:517-22. [DOI: 10.1016/j.ijcard.2014.10.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
38 McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; Authors/Task Force Members:., ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022;24:4-131. [PMID: 35083827 DOI: 10.1002/ejhf.2333] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599-726. [PMID: 34447992 DOI: 10.1093/eurheartj/ehab368] [Cited by in Crossref: 209] [Cited by in F6Publishing: 73] [Article Influence: 209.0] [Reference Citation Analysis]
40 Saraon T, Katz SD. Targeting Iron Deficiency Anemia in Heart Failure. Prog Cardiovasc Dis 2016;58:407-15. [PMID: 26657161 DOI: 10.1016/j.pcad.2015.11.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
41 Ponikowska M, Tupikowska M, Kasztura M, Jankowska EA, Szepietowski JC. Deranged iron status in psoriasis: the impact of low body mass. J Cachexia Sarcopenia Muscle 2015;6:358-64. [PMID: 26673741 DOI: 10.1002/jcsm.12061] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
42 Suzuki T, Hanawa H, Jiao S, Ohno Y, Hayashi Y, Yoshida K, Kashimura T, Obata H, Minamino T. Inappropriate expression of hepcidin by liver congestion contributes to anemia and relative iron deficiency. J Card Fail 2014;20:268-77. [PMID: 24440572 DOI: 10.1016/j.cardfail.2014.01.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
43 Fillet M, Deroyer C, Cobraiville G, Le Goff C, Cavalier E, Chapelle JP, Marée R, Legrand V, Pierard L, Kolh P, Merville MP. Identification of protein biomarkers associated with cardiac ischemia by a proteomic approach. Biomarkers 2013;18:614-24. [PMID: 24044526 DOI: 10.3109/1354750X.2013.838306] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Vlahakos DV, Tsioufis C, Manolis A, Filippatos G, Marathias KP, Papademetriou V, Mancia G. Inhibition of the renin-angiotensin system in the cardiorenal syndrome with anaemia: a double-edged sword. J Hypertens 2019;37:2145-53. [PMID: 31490340 DOI: 10.1097/HJH.0000000000002111] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
45 Jankowska EA, Tkaczyszyn M, Ponikowski P. Myocardial iron content in non-ischaemic cardiomyopathy: how much is known? Eur J Heart Fail 2020;22:2047-8. [PMID: 33034152 DOI: 10.1002/ejhf.2023] [Reference Citation Analysis]
46 Nielsen OH, Soendergaard C, Vikner ME, Weiss G. Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease. Nutrients 2018;10:E82. [PMID: 29342861 DOI: 10.3390/nu10010082] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
47 Ebner N, von Haehling S. Iron deficiency in heart failure: a practical guide. Nutrients 2013;5:3730-9. [PMID: 24064572 DOI: 10.3390/nu5093730] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
48 Metra M, Teerlink JR. Heart failure. The Lancet 2017;390:1981-95. [DOI: 10.1016/s0140-6736(17)31071-1] [Cited by in Crossref: 242] [Cited by in F6Publishing: 98] [Article Influence: 48.4] [Reference Citation Analysis]
49 Sîrbu O, Floria M, Dascalita P, Stoica A, Adascalitei P, Sorodoc V, Sorodoc L. Anemia in heart failure - from guidelines to controversies and challenges. Anatol J Cardiol 2018;20:52-9. [PMID: 29952364 DOI: 10.14744/AnatolJCardiol.2018.08634] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
50 Ponikowska B, Suchocki T, Paleczny B, Olesinska M, Powierza S, Borodulin-Nadzieja L, Reczuch K, von Haehling S, Doehner W, Anker SD, Cleland JG, Jankowska EA. Iron status and survival in diabetic patients with coronary artery disease. Diabetes Care 2013;36:4147-56. [PMID: 24130349 DOI: 10.2337/dc13-0528] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
51 McDonagh T, Macdougall IC. Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral? Eur J Heart Fail. 2015;17:248-262. [PMID: 25639592 DOI: 10.1002/ejhf.236] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 10.9] [Reference Citation Analysis]
52 Macdougall IC, Comin-Colet J, Breymann C, Spahn DR, Koutroubakis IE. Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency. Adv Ther 2020;37:1960-2002. [PMID: 32297281 DOI: 10.1007/s12325-020-01323-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129-2200. [PMID: 27206819 DOI: 10.1093/eurheartj/ehw128] [Cited by in Crossref: 6518] [Cited by in F6Publishing: 5061] [Article Influence: 1086.3] [Reference Citation Analysis]
54 Lam CSP, Doehner W, Comin-Colet J; IRON CORE Group. Iron deficiency in chronic heart failure: case-based practical guidance. ESC Heart Fail 2018;5:764-71. [PMID: 30073785 DOI: 10.1002/ehf2.12333] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
55 Beguin Y, Jaspers A. Iron sucrose - characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas. Expert Opin Pharmacother 2014;15:2087-103. [PMID: 25186219 DOI: 10.1517/14656566.2014.953928] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
56 Valente de Souza L, Hoffmann A, Weiss G. Impact of bacterial infections on erythropoiesis. Expert Rev Anti Infect Ther 2021;19:619-33. [PMID: 33092423 DOI: 10.1080/14787210.2021.1841636] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
57 Hsieh YP, Huang CH, Lee CY, Lin CY, Chang CC. Silencing of hepcidin enforces the apoptosis in iron-induced human cardiomyocytes. J Occup Med Toxicol 2014;9:11. [PMID: 24641804 DOI: 10.1186/1745-6673-9-11] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
58 Arias-Barrera C, Palacios-Ariza MA, Pradilla I, Alvarez-Moreno C. A cohort study of two intravenous treatments for iron deficiency in patients with heart failure. Acta Cardiol 2019;:1-8. [PMID: 31298975 DOI: 10.1080/00015385.2019.1639270] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
59 McDonagh T, Damy T, Doehner W, Lam CSP, Sindone A, van der Meer P, Cohen-Solal A, Kindermann I, Manito N, Pfister O, Pohjantähti-Maaroos H, Taylor J, Comin-Colet J. Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice. Eur J Heart Fail 2018;20:1664-72. [PMID: 30311713 DOI: 10.1002/ejhf.1305] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 9.5] [Reference Citation Analysis]
60 Weinmann K, Werner J, Rottbauer W, Keßler M. Immunoadsorption for heart failure is associated with normalization of iron metabolism. Biomarkers 2021;26:395-400. [PMID: 33843393 DOI: 10.1080/1354750X.2021.1904001] [Reference Citation Analysis]
61 Ebner N, Jankowska EA, Ponikowski P, Lainscak M, Elsner S, Sliziuk V, Steinbeck L, Kube J, Bekfani T, Scherbakov N, Valentova M, Sandek A, Doehner W, Springer J, Anker SD, von Haehling S. The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure. Int J Cardiol 2016;205:6-12. [PMID: 26705670 DOI: 10.1016/j.ijcard.2015.11.178] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 8.6] [Reference Citation Analysis]
62 Ponikowski P, Jankowska EA. Targeting Iron Deficiency in Heart Failure: Existing Evidence and Future Expectations. Circ Heart Fail 2021;14:e008299. [PMID: 34003689 DOI: 10.1161/CIRCHEARTFAILURE.121.008299] [Reference Citation Analysis]
63 Cho ME, Hansen JL, Peters CB, Cheung AK, Greene T, Sauer BC. An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic Veterans with predialysis chronic kidney disease. Kidney International 2019;96:750-60. [DOI: 10.1016/j.kint.2019.04.029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
64 Jankowska EA, Tkaczyszyn M, Drozd M, Ponikowski P. Monitoring of iron status in patients with heart failure. Eur Heart J Suppl 2019;21:M32-5. [PMID: 31908613 DOI: 10.1093/eurheartj/suz231] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
65 Jankowska EA, Drozd M, Ponikowski P. Iron Deficiency Treatment in Patients with Heart Failure. Handb Exp Pharmacol 2017;243:561-76. [PMID: 28405775 DOI: 10.1007/164_2017_30] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
66 Mordi IR, Tee A, Lang CC. Iron Therapy in Heart Failure: Ready for Primetime? Card Fail Rev 2018;4:28-32. [PMID: 29892473 DOI: 10.15420/cfr.2018:6:2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
67 Przybylowski P, Wasilewski G, Golabek K, Bachorzewska-Gajewska H, Dobrzycki S, Koc-Zorawska E, Malyszko J. Absolute and Functional Iron Deficiency Is a Common Finding in Patients With Heart Failure and After Heart Transplantation. Transplant Proc 2016;48:173-6. [PMID: 26915864 DOI: 10.1016/j.transproceed.2015.12.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
68 Krim D, Gomolin A, Czuzoj-Shulman N, Abenhaim HA. Maternal and neonatal outcomes of births to women with psoriasis: a population-based cohort of 13 million births. J Matern Fetal Neonatal Med 2021;:1-8. [PMID: 34961404 DOI: 10.1080/14767058.2021.2020238] [Reference Citation Analysis]
69 Haddad S, Wang Y, Galy B, Korf-Klingebiel M, Hirsch V, Baru AM, Rostami F, Reboll MR, Heineke J, Flögel U, Groos S, Renner A, Toischer K, Zimmermann F, Engeli S, Jordan J, Bauersachs J, Hentze MW, Wollert KC, Kempf T. Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure. Eur Heart J 2017;38:362-72. [PMID: 27545647 DOI: 10.1093/eurheartj/ehw333] [Cited by in Crossref: 28] [Cited by in F6Publishing: 44] [Article Influence: 5.6] [Reference Citation Analysis]
70 Mentz RJ, Ambrosy AP, Ezekowitz JA, Lewis GD, Butler J, Wong YW, De Pasquale CG, Troughton RW, O'Meara E, Rockhold FW, Garg J, Samsky MD, Leloudis D, Dugan M, Mundy LM, Hernandez AF; HEART-FID Trial Investigators. Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron Deficiency: Rationale and Design. Circ Heart Fail 2021;14:e008100. [PMID: 34003690 DOI: 10.1161/CIRCHEARTFAILURE.120.008100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Schou M, Bosselmann H, Gaborit F, Iversen K, Goetze JP, Soletomas G, Rasmussen J, Kistorp C, Kober L, Gustafsson F, Tonder N. Iron deficiency: Prevalence and relation to cardiovascular biomarkers in heart failure outpatients. Int J Cardiol 2015;195:143-8. [PMID: 26043148 DOI: 10.1016/j.ijcard.2015.05.096] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
72 Dichtl S, Haschka D, Nairz M, Seifert M, Volani C, Lutz O, Weiss G. Dopamine promotes cellular iron accumulation and oxidative stress responses in macrophages. Biochem Pharmacol 2018;148:193-201. [PMID: 29208364 DOI: 10.1016/j.bcp.2017.12.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
73 Hohl M, Ardehali H, Azuaje FJ, Breckenridge RA, Doehner W, Eaton P, Ehret GB, Fujita T, Gaetani R, Giacca M, Hasenfuß G, Heymans S, Leite-Moreira AF, Linke WA, Linz D, Lyon A, Mamas MA, Orešič M, Papp Z, Pedrazzini T, Piepoli M, Prosser B, Rizzuto R, Tarone G, Tian R, van Craenenbroeck E, van Rooij E, Wai T, Weiss G, Maack C. Meeting highlights from the 2013 European Society of Cardiology Heart Failure Association Winter Meeting on Translational Heart Failure Research. Eur J Heart Fail 2014;16:6-14. [PMID: 24453095 DOI: 10.1002/ejhf.10] [Reference Citation Analysis]
74 Cunha GJ, Rocha BM, Menezes Falcão L. Iron deficiency in chronic and acute heart failure: A contemporary review on intertwined conditions. European Journal of Internal Medicine 2018;52:1-7. [DOI: 10.1016/j.ejim.2018.04.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
75 Cases Amenós A, Ojeda López R, Portolés Pérez JM. Insuficiencia cardíaca en la enfermedad renal y déficit de hierro: importancia de la ferroterapia. Nefrología 2017;37:587-91. [DOI: 10.1016/j.nefro.2017.03.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
76 Jankowska EA, Ponikowski P. Intravenous iron supplementation: novel anti-remodelling therapy for patients with heart failure? Eur Heart J 2021;42:4915-8. [PMID: 34519349 DOI: 10.1093/eurheartj/ehab624] [Reference Citation Analysis]
77 Otaki Y, Watanabe T, Takahashi H, Narumi T, Kadowaki S, Honda Y, Arimoto T, Shishido T, Miyamoto T, Konta T, Kubota I. Association of renal tubular damage with cardio-renal anemia syndrome in patients with heart failure. International Journal of Cardiology 2014;173:222-8. [DOI: 10.1016/j.ijcard.2014.02.044] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
78 Wong CC, Ng AC, Kritharides L, Sindone AP. Iron Deficiency in Heart Failure: Looking Beyond Anaemia. Heart, Lung and Circulation 2016;25:209-16. [DOI: 10.1016/j.hlc.2015.06.827] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
79 Dziegala M, Kobak KA, Kasztura M, Bania J, Josiak K, Banasiak W, Ponikowski P, Jankowska EA. Iron Depletion Affects Genes Encoding Mitochondrial Electron Transport Chain and Genes of Non-Oxidative Metabolism, Pyruvate Kinase and Lactate Dehydrogenase, in Primary Human Cardiac Myocytes Cultured upon Mechanical Stretch. Cells 2018;7:E175. [PMID: 30347796 DOI: 10.3390/cells7100175] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
80 Koleini N, Shapiro JS, Geier J, Ardehali H. Ironing out mechanisms of iron homeostasis and disorders of iron deficiency. J Clin Invest 2021;131:148671. [PMID: 34060484 DOI: 10.1172/JCI148671] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
81 Roman MA, Abbasciano RG, Pathak S, Oo S, Yusoff S, Wozniak M, Qureshi S, Lai FY, Kumar T, Richards T, Yao G, Estcourt L, Murphy GJ. Patient blood management interventions do not lead to important clinical benefits or cost-effectiveness for major surgery: a network meta-analysis. Br J Anaesth 2021;126:149-56. [PMID: 32620259 DOI: 10.1016/j.bja.2020.04.087] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
82 Anand I, Gupta P. How I treat anemia in heart failure. Blood 2020;136:790-800. [PMID: 31895946 DOI: 10.1182/blood.2019004004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
83 Altman NL, Patel A. Intravenous Iron Therapy in Heart Failure. Heart Fail Clin 2018;14:537-43. [PMID: 30266362 DOI: 10.1016/j.hfc.2018.06.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
84 Rizzo C, Carbonara R, Ruggieri R, Passantino A, Scrutinio D. Iron Deficiency: A New Target for Patients With Heart Failure. Front Cardiovasc Med 2021;8:709872. [PMID: 34447793 DOI: 10.3389/fcvm.2021.709872] [Reference Citation Analysis]
85 Miñana G, Santas E, de la Espriella R, Núñez E, Lorenzo M, Núñez G, Valero E, Bodí V, Chorro FJ, Sanchis J, Cohen-Solal A, Bayés-Genís A, Núñez J. Right ventricular function and iron deficiency in acute heart failure. Eur Heart J Acute Cardiovasc Care 2021;10:406-14. [PMID: 33620455 DOI: 10.1093/ehjacc/zuaa028] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
86 Cappellini MD, Musallam KM, Taher AT. Iron deficiency anaemia revisited. J Intern Med 2020;287:153-70. [PMID: 31665543 DOI: 10.1111/joim.13004] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 15.3] [Reference Citation Analysis]
87 Lupu M, Tudor DV, Filip GA. Influence of mitochondrial and systemic iron levels in heart failure pathology. Heart Fail Rev 2019;24:647-59. [PMID: 31016425 DOI: 10.1007/s10741-019-09788-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
88 Kang CK, Pope M, Lang CC, Kalra PR. Iron deficiency in heart failure: Efficacy and safety of intravenous iron therapy. Cardiovasc Ther 2017;35. [PMID: 28836730 DOI: 10.1111/1755-5922.12301] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
89 Feng K, Liu Y, Sun J, Zhao C, Duan Y, Wang W, Yan K, Yan X, Sun H, Hu Y, Han J. Compound Danshen Dripping Pill inhibits doxorubicin or isoproterenol-induced cardiotoxicity. Biomed Pharmacother 2021;138:111531. [PMID: 34311530 DOI: 10.1016/j.biopha.2021.111531] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 van der Wal HH, van Deursen VM, van der Meer P, Voors AA. Comorbidities in Heart Failure. Handb Exp Pharmacol 2017;243:35-66. [PMID: 28382470 DOI: 10.1007/164_2017_27] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 3.2] [Reference Citation Analysis]
91 Jankowska EA, Tkaczyszyn M, Suchocki T, Drozd M, von Haehling S, Doehner W, Banasiak W, Filippatos G, Anker SD, Ponikowski P. Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials. Eur J Heart Fail 2016;18:786-95. [PMID: 26821594 DOI: 10.1002/ejhf.473] [Cited by in Crossref: 172] [Cited by in F6Publishing: 146] [Article Influence: 28.7] [Reference Citation Analysis]
92 Zeller T, Altay A, Waldeyer C, Appelbaum S, Ojeda F, Ruhe J, Schnabel RB, Lackner KJ, Blankenberg S, Karakas M. Prognostic Value of Iron-Homeostasis Regulating Peptide Hepcidin in Coronary Heart Disease-Evidence from the Large AtheroGene Study. Biomolecules 2018;8:E43. [PMID: 29958400 DOI: 10.3390/biom8030043] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
93 Vishram-Nielsen JKK, Tomasoni D, Gustafsson F, Metra M. Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction. Drugs 2022. [PMID: 35113350 DOI: 10.1007/s40265-021-01666-z] [Reference Citation Analysis]
94 Vyoral D, Jiri Petrak. Therapeutic potential of hepcidin − the master regulator of iron metabolism. Pharmacological Research 2017;115:242-54. [DOI: 10.1016/j.phrs.2016.11.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 5.2] [Reference Citation Analysis]
95 Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-juanatey JR, Harjola V, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; Authors/Task Force Members, Document Reviewers. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the spec. Eur J Heart Fail 2016;18:891-975. [DOI: 10.1002/ejhf.592] [Cited by in Crossref: 3626] [Cited by in F6Publishing: 3057] [Article Influence: 604.3] [Reference Citation Analysis]
96 Enjuanes C, Bruguera J, Grau M, Cladellas M, Gonzalez G, Meroño O, Moliner-Borja P, Verdú JM, Farré N, Comín-Colet J. Iron Status in Chronic Heart Failure: Impact on Symptoms, Functional Class and Submaximal Exercise Capacity. Rev Esp Cardiol (Engl Ed) 2016;69:247-55. [PMID: 26684058 DOI: 10.1016/j.rec.2015.08.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 0.3] [Reference Citation Analysis]
97 Bojarczuk J, Josiak K, Kasztura M, Kustrzycka-Kratochwil D, Nowak K, Jagielski D, Banasiak W, Jankowska EA, Ponikowski P. Iron deficiency in heart failure: Impact on response to cardiac resynchronization therapy. Int J Cardiol 2016;222:133-4. [PMID: 27494725 DOI: 10.1016/j.ijcard.2016.07.280] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
98 Kobak K, Kasztura M, Dziegala M, Bania J, Kapuśniak V, Banasiak W, Ponikowski P, Jankowska EA. Iron limitation promotes the atrophy of skeletal myocytes, whereas iron supplementation prevents this process in the hypoxic conditions. Int J Mol Med 2018;41:2678-86. [PMID: 29436580 DOI: 10.3892/ijmm.2018.3481] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
99 O'Meara E, Rouleau JL, White M, Roy K, Blondeau L, Ducharme A, Neagoe PE, Sirois MG, Lavoie J, Racine N, Liszkowski M, Madore F, Tardif JC, de Denus S; ANCHOR Investigators. Heart failure with anemia: novel findings on the roles of renal disease, interleukins, and specific left ventricular remodeling processes. Circ Heart Fail 2014;7:773-81. [PMID: 25027873 DOI: 10.1161/CIRCHEARTFAILURE.114.001100] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 3.9] [Reference Citation Analysis]
100 Enjuanes C, Bruguera J, Grau M, Cladellas M, Gonzalez G, Meroño O, Moliner-borja P, Verdú JM, Farré N, Comín-colet J. Estado del hierro en la insuficiencia cardiaca crónica: impacto en síntomas, clase funcional y capacidad de ejercicio submáxima. Revista Española de Cardiología 2016;69:247-55. [DOI: 10.1016/j.recesp.2015.08.017] [Cited by in Crossref: 41] [Cited by in F6Publishing: 20] [Article Influence: 6.8] [Reference Citation Analysis]
101 Anand IS, Gupta P. Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies. Circulation 2018;138:80-98. [DOI: 10.1161/circulationaha.118.030099] [Cited by in Crossref: 95] [Cited by in F6Publishing: 42] [Article Influence: 23.8] [Reference Citation Analysis]
102 Vela D. Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology. Lab Invest. 2018;98:315-326. [PMID: 29058707 DOI: 10.1038/labinvest.2017.111] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
103 Tkaczyszyn M, Jankowska EA. Iron deficiency and red cell indices in patients with heart failure: reply. Eur J Heart Fail 2018;20:828-9. [PMID: 29280305 DOI: 10.1002/ejhf.1092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
104 Vlahakos V, Marathias K, Lionaki S, Loukides S, Zakynthinos S, Vlahakos D. The Paradigm Shift from Polycythemia to Anemia in COPD: The Critical Role of the Renin-Angiotensin System Inhibitors. Expert Rev Respir Med 2022. [PMID: 35212601 DOI: 10.1080/17476348.2022.2045958] [Reference Citation Analysis]
105 Barberan-garcia A, Rodríguez DA, Blanco I, Gea J, Torralba Y, Arbillaga-etxarri A, Barberà JA, Vilaró J, Roca J, Orozco-levi M. Non-anaemic iron deficiency impairs response to pulmonary rehabilitation in COPD: Non-anaemic iron deficiency in COPD. Respirology 2015;20:1089-95. [DOI: 10.1111/resp.12591] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
106 Sierpinski R, Josiak K, Suchocki T, Wojtas-Polc K, Mazur G, Butrym A, Rozentryt P, van der Meer P, Comin-Colet J, von Haehling S, Kosmala W, Przewlocka-Kosmala M, Banasiak W, Nowak J, Voors AA, Anker SD, Cleland JGF, Ponikowski P, Jankowska EA. High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality. Eur J Heart Fail 2021;23:919-32. [PMID: 33111457 DOI: 10.1002/ejhf.2036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
107 Jankowska EA, Kasztura M, Sokolski M, Bronisz M, Nawrocka S, Oleśkowska-Florek W, Zymliński R, Biegus J, Siwołowski P, Banasiak W, Anker SD, Filippatos G, Cleland JG, Ponikowski P. Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure. Eur Heart J 2014;35:2468-76. [PMID: 24927731 DOI: 10.1093/eurheartj/ehu235] [Cited by in Crossref: 110] [Cited by in F6Publishing: 92] [Article Influence: 13.8] [Reference Citation Analysis]
108 Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V, McDonagh T, Parkhomenko A, Tavazzi L, Levesque V, Mori C, Roubert B, Filippatos G, Ruschitzka F, Anker SD; CONFIRM-HF Investigators. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†. Eur Heart J 2015;36:657-68. [PMID: 25176939 DOI: 10.1093/eurheartj/ehu385] [Cited by in Crossref: 520] [Cited by in F6Publishing: 423] [Article Influence: 65.0] [Reference Citation Analysis]
109 Cappellini MD, Comin-Colet J, de Francisco A, Dignass A, Doehner W, Lam CS, Macdougall IC, Rogler G, Camaschella C, Kadir R, Kassebaum NJ, Spahn DR, Taher AT, Musallam KM; IRON CORE Group. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management. Am J Hematol 2017;92:1068-78. [PMID: 28612425 DOI: 10.1002/ajh.24820] [Cited by in Crossref: 137] [Cited by in F6Publishing: 111] [Article Influence: 27.4] [Reference Citation Analysis]
110 Krzysztofik J, Ponikowski P. Current and emerging pharmacologic options for the management of patients with chronic and acute decompensated heart failure. Expert Rev Clin Pharmacol 2017;10:517-34. [PMID: 28358228 DOI: 10.1080/17512433.2017.1299574] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
111 Magrì D, De Martino F, Moscucci F, Agostoni P, Sciomer S. Anemia and Iron Deficiency in Heart Failure. Heart Failure Clinics 2019;15:359-69. [DOI: 10.1016/j.hfc.2019.02.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
112 Locatelli F, Del Vecchio L, Minutolo R, De Nicola L. Anemia: A Connection Between Heart Failure and Kidney Failure. Cardiol Clin 2021;39:319-33. [PMID: 34247747 DOI: 10.1016/j.ccl.2021.04.003] [Reference Citation Analysis]
113 Shukla SK, Sikder K, Sarkar A, Addya S, Rafiq K. Molecular network, pathway, and functional analysis of time-dependent gene changes related to cathepsin G exposure in neonatal rat cardiomyocytes. Gene 2018;671:58-66. [PMID: 29859287 DOI: 10.1016/j.gene.2018.05.110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
114 Rocha BML, Cunha GJL, Menezes Falcão LF. The Burden of Iron Deficiency in Heart Failure: Therapeutic Approach. J Am Coll Cardiol 2018;71:782-93. [PMID: 29447741 DOI: 10.1016/j.jacc.2017.12.027] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 15.0] [Reference Citation Analysis]
115 Nikolaou M, Chrysohoou C, Georgilas TA, Giamouzis G, Giannakoulas G, Karavidas A, Papadopoulos C, Patsilinakos S, Tziakas D, Parissis J; Hellenic Iron Consensus Group. Management of iron deficiency in chronic heart failure: Practical considerations for clinical use and future directions. Eur J Intern Med 2019;65:17-25. [PMID: 31109847 DOI: 10.1016/j.ejim.2019.05.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
116 Osadnik T, Strzelczyk J, Hawranek M, Lekston A, Wasilewski J, Kurek A, Gutowski AR, Wilczek K, Dyrbuś K, Gierlotka M, Wiczkowski A, Gąsior M, Szafranek A, Poloński L. Red cell distribution width is associated with long-term prognosis in patients with stable coronary artery disease. BMC Cardiovasc Disord 2013;13:113. [PMID: 24320974 DOI: 10.1186/1471-2261-13-113] [Cited by in Crossref: 29] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
117 Boman K, Olofsson M, Bergman AR, Brännström M. Anaemia, but not iron deficiency, is associated with clinical symptoms and quality of life in patients with severe heart failure and palliative home care: A substudy of the PREFER trial. Eur J Intern Med 2017;46:35-40. [PMID: 28899603 DOI: 10.1016/j.ejim.2017.08.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
118 Manito N, Cerqueiro J, Comín-colet J, García-pinilla J, González-franco A, Grau-amorós J, Peraira J, Manzano L. Documento de consenso de la Sociedad Española de Cardiología y la Sociedad Española de Medicina Interna sobre el diagnóstico y tratamiento del déficit de hierro en la insuficiencia cardíaca. Revista Clínica Española 2017;217:35-45. [DOI: 10.1016/j.rce.2016.08.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 3.8] [Reference Citation Analysis]
119 Nielsen OH, Ainsworth M, Coskun M, Weiss G. Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review. Medicine (Baltimore) 2015;94:e963. [PMID: 26061331 DOI: 10.1097/MD.0000000000000963] [Cited by in Crossref: 43] [Cited by in F6Publishing: 19] [Article Influence: 6.1] [Reference Citation Analysis]
120 Ambrosy AP, Lewis GD, Malhotra R, Jones AD, Greene SJ, Fudim M, Coles A, Butler J, Sharma A, Hernandez AF, Mentz RJ. Identifying responders to oral iron supplementation in heart failure with a reduced ejection fraction: a post-hoc analysis of the IRONOUT-HF trial. J Cardiovasc Med (Hagerstown) 2019;20:223-5. [PMID: 30540649 DOI: 10.2459/JCM.0000000000000736] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
121 Michel JB, Martin-Ventura JL. Red Blood Cells and Hemoglobin in Human Atherosclerosis and Related Arterial Diseases. Int J Mol Sci 2020;21:E6756. [PMID: 32942605 DOI: 10.3390/ijms21186756] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
122 Vela D. Keeping heart homeostasis in check through the balance of iron metabolism. Acta Physiol 2019;228. [DOI: 10.1111/apha.13324] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
123 Carrilho P. Intravenous iron in heart failure and chronic kidney disease. Nefrología (English Edition) 2021;41:403-11. [DOI: 10.1016/j.nefroe.2021.10.007] [Reference Citation Analysis]
124 Carrilho P. Intravenous iron in heart failure and chronic kidney disease. Nefrologia 2021;41:403-11. [PMID: 33250198 DOI: 10.1016/j.nefro.2020.07.009] [Reference Citation Analysis]
125 Simon S, Ioannou A, Deoraj S, Metaxa S, Mandal AKJ, Missouris CG. Audit of the prevalence and investigation of iron deficiency anaemia in patients with heart failure in hospital practice. Postgrad Med J 2020;96:206-11. [PMID: 31732510 DOI: 10.1136/postgradmedj-2019-136867] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
126 Loncar G, Obradovic D, Thiele H, von Haehling S, Lainscak M. Iron deficiency in heart failure. ESC Heart Fail 2021;8:2368-79. [PMID: 33932115 DOI: 10.1002/ehf2.13265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Dalal J, Katekhaye V, Jain R. Effect of ferric carboxymaltose on hospitalization and mortality outcomes in chronic heart failure: A meta-analysis. Indian Heart J 2017;69:736-41. [PMID: 29174251 DOI: 10.1016/j.ihj.2017.10.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
128 Jankowska EA, Ponikowski P. Dilemmas on diagnosis and treatment of iron deficiency in patients after an episode of acute heart failure. Eur Heart J 2021:ehab839. [PMID: 34888632 DOI: 10.1093/eurheartj/ehab839] [Reference Citation Analysis]